Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.31695 | 12 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.3041 | 12 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.30468 | 12 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.22294 | 11 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.24584 | 12 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.36151 | 12 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.89208 | 37 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.28317 | 12 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.27217 | 12 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.26501 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.28561 | 12 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.2749 | 12 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.30155 | 12 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.29045 | 12 |